This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Cramer's 'Mad Money' Recap: Making Sense of the Rally

Ward also touted CSX's new hub in Ohio as opening new markets for the company and providing customers with higher levels of service than ever before.

Cramer called CSX a cheap stock and one that's not yet done going higher.

Unlocking Value

In the second "Executive Decision" segment, Cramer spoke with Joe Almeida, chairman, president and CEO of Covidien (COV), the biotech firm that's spinning off its lagging pharmaceuticals business to unlock the full value in its red-hot medical device segment. Covidien beat Wall Street estimates by 1 cent a share on a 2.8% rise in revenue.

Almeida said that Covidien is all about choices, which is why the company is focused on a portfolio of great products and allocates capital smartly to those products. He said Covidien's portfolio is balanced not just among products but also among geographies, with a focus on emerging markets.

Almeida credited Covidien's research and development efforts as allowing the company to enjoy organic growth year after year. He said his company invests heavily in research and is opening new R&D centers in India and China to exclusively help bring devices to those emerging markets.

As the battle over health care continues here in the U.S., Almeida told investors the vast majority of Covidien's products are life-saving devices and only a small fraction are elective procedures.

Cramer continued his support for Covidien given the company's good balance sheet, extensive research and development and great product portfolio. He said that when Europe knocks the markets down, stocks like Covidien are the ones investors should be buying on the cheap.

Lightning Round

Here's what Cramer had to say about callers' stocks during the "Lightning Round":

Align Technology (ALGN): "I happen to like the company very much. I want to stand buy it, it's terrific."

LG Display (LPL): "I'm not going to Korea for stocks, I've got enough problems with U.S. stocks. If you want exposure to Apple (AAPL), go buy Apple."

Kellogg (K): "I think Kellogg is poorly run. Hershey Foods (HSY) had a great quarter. Kellogg can't seem to do anything right. I say no until it yields 4.5%."

2 of 4

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
ZNGA $2.78 0.36%
COV $106.71 -1.26%
CSX $33.35 0.45%
S $4.75 0.64%
AAPL $126.37 2.53%


DOW 17,976.31 +263.65 1.49%
S&P 500 2,086.24 +25.22 1.22%
NASDAQ 4,947.4410 +56.2220 1.15%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs